Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269

Maria Stella,Maria Giuliani,Alessia Biolchi,Sara Tomei,Rosita De Paola,Xilian Bai,Ray Borrow,Jay Lucidarme,Rita La Gaetana,Daniela Toneatto,Mariagrazia Pizza,Laura Serino,Elena Mori,Marzia Monica Giuliani

Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269

2019

Maria Stella
Maria Giuliani
Alessia Biolchi
Sara Tomei
Rosita De Paola
Xilian Bai
Ray Borrow
Jay Lucidarme
Rita La Gaetana
Daniela Toneatto
Mariagrazia Pizza
Laura Serino
Elena Mori
Marzia Monica Giuliani

AbstractThe Meningococcal Antigen Typing System (MATS) has been developed as an hSBA surrogate to evaluate potential coverage afforded by the 4-component meningococcal serogroup B vaccine (4CMenB: ...

Keywords:

Neisseria meningitidis
Meningococcal antigen
Vaccination
Virology
Typing
Serum Bactericidal Antibody Assay
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations